Overview
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
1 of 6 financial statements was filed late (for 2024, 8 days late). All were audited by a statutory auditor.
- 202515/07/2026
- 202423/07/2025
- 202315/07/2024
- 202205/07/2023
- 202105/07/2022
- 202031/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Sanctions and PEP lists
| Person | List | Match | |
|---|---|---|---|
| Mateusz Zurzycki | Członek organu spółki Skarbu Państwa | confirmed |
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The company is represented by two members of the management board acting jointly, or one member of the management board jointly with a commercial proxy, and if the management board consists of one person, by one member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bielówka Fundacja Rodzinna w Organizacji | 1 | $1,739.61 | 25.9647% |
| 1 | $1,347.09 | 20.1062% | |
Molo Fundacja Rodzinna w Organizacji | 1 | $1,343.43 | 20.0514% |
Satus Fundacja Rodzinna | 1 | $1,168.19 | 17.436% |
Others | 1 | $1,101.57 | 16.4417% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Phonemic sp. z o.o. | 5,402.49 USD | 11.7647% | ||
Drukuje.To sp. z o.o. | 2,025.93 USD | 15% | ||
Amorphis Pharma Development sp. z o.o. | 229.61 USD | 14.5299% |
Bank accounts
Was a VAT taxpayer from 2015-07-01 to 2023-05-19.
Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
7 notices recorded in the Court and Commercial Gazette (MSiG).
| Publication date | Event | |
|---|---|---|
| Jul 16, 2026 | Call to creditors | |
| Aug 1, 2023 | Call to creditors | |
| Apr 11, 2023 | Call to creditors | |
| Jan 2, 2023 | Call to creditors | |
| Jul 13, 2022 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2017 | Aid for SME access to finance — aid for start-ups | $1.3M$1,270,614 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Forum Towarzystwo Funduszy Inwestycyjnych S.A. | $26,345,866.20 | forumtfi.pl | ||
| Gravier Investment S.A. | $7,665,294.01 | gravier.pl | ||
| Bitspiration Booster sp. z o.o. | $679,167.75 | bitspiration.vc | ||
| Amathus Towarzystwo Funduszy Inwestycyjnych S.A. | $274,175.29 | amathus.pl | ||
| One Vision Capital sp. z o.o. | $197,142.32 | 1vc.pl | ||
| Blite Fund sp. z o.o. | $152,277.66 | blitefund.com | ||
| Genesis Capital Invest S.K.A. | $73,406.18 | asiinvest.integra-management.pl | ||
| Erebor Capital sp. z o.o. | $64,144.32 | erebor.capital | ||
| Imperio S.A. | $-16,574.59 | imperioasi.pl | ||
| Skylark Partners sp. z o.o. | – | skylark.partners |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-10 | Address change (Ul. Podole 60, 30-394, Kraków → Józefa Dietla 99/4a, 31-031, Kraków) | |
| 2023-06-21 | Share capital reduction (25,259.00 PLN → 24,803.00 PLN) | |
| 2022-11-30 | Share capital reduction (25,759.00 PLN → 25,259.00 PLN) | |
| 2021-06-23 | Share capital increase (25,314.00 PLN → 25,759.00 PLN) | |
| 2021-01-26 | Share capital increase (24,814.00 PLN → 25,314.00 PLN) |
FAQ
Last updated: 2026-07-17